IL6R and neoplasm: Combined with ovalbumin immunization (Figures S5A and S5B), PD-L1 blockade increased the polyfunctional anti-tumor CTL response in mice that received Il6r−/− OT-I cells, but not Il6rwt/wt cells (Figures S5C and S5D).